Status:
RECRUITING
Prospective Prostate Cancer and Patient-reported Outcomes Registry
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Collaborating Sponsors:
AZ Sint-Jan AV
General Hospital Groeninge
Conditions:
Prostate Cancer
Adenocarcinoma of the Prostate
Eligibility:
MALE
18+ years
Brief Summary
This study aims to evaluate the use of a digital solution, integrated into the electronic health record, for prospective and structured reporting of clinical and patient-reported outcomes for patients...
Eligibility Criteria
Inclusion
- Pathology confirmed diagnosis of localized or locally advanced prostate cancer
- Being able to speak, read and understand Dutch, French, or English
- Each patient (or their legally acceptable representative) must sign an informed consent form (ICF) indicating that he understands the purpose of, and is willing to participate in the study.
Exclusion
- Patients with prior treatment for prostate malignancies will be excluded.
- Dementia, mental alteration, or psychiatric pathology that can compromise informed consent from the patient and/ or adherence to the protocol and the monitoring of the trial
- Patients who cannot submit themselves to following the protocol for psychological reasons, social, family, or geographical.
- Persons deprived of liberty or under guardianship
Key Trial Info
Start Date :
October 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2030
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT04694924
Start Date
October 1 2020
End Date
October 1 2030
Last Update
May 22 2024
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
AZ Sint-Blasius
Dendermonde, Oost-Vlaanderen, Belgium, 9200
2
University Hospitals Leuven
Leuven, Vlaams-Brabant, Belgium, 3000
3
AZ Sint-Jan Brugge
Bruges, West-Vlaanderen, Belgium, 8000
4
AZ Groeninge Kortrijk
Kortrijk, West-Vlaanderen, Belgium, 8500